
|Videos|October 11, 2016
EGFR Testing for Metastatic Non-Small Cell Lung Cancer with Jonathan W. Riess, MD, MS: Case 3
EGFR Testing for Metastatic Non-Small Cell Lung Cancer with Jonathan W. Riess, MD, MS
Advertisement
Riess case 3:
68-year-old woman undergoing plasma testing for EGFR T790M Mutation.
- The patient is a 68-year-old woman previously diagnosed with adenocarcinoma
- She later developed growth of her primary tumor and several pulmonary nodules.
- She complained of shortness of breath
- Biopsy tissue was insufficient for mutation testing; plasma testing showed the presence of T790M
- After being switched to osimertinib, the patient has sustained disease control
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ASCO 2026 GU Cancer Highlights: Beyond the LBAs
2
Dr Cloughesy on Extended Follow-Up Data for Vorasidenib in IDH1/2 Mutant Glioma
3
Bispecific ADC Iza-Bren Extends Survival in Advanced TNBC
4
FDA Approves Generic Eribulin Mesylate for Metastatic Breast Cancer
5

































